Hjem › Dermatomyositt › Illinois
Kliniske studier for Dermatomyositt i Illinois
3 studier for Dermatomyositt søker deltakere på steder i Illinois.
Offisiell studietekst (engelsk)
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
- Research Site, Willowbrook
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06455449RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- Ann & Robert H. Lurie Children's Hospital of Chicago - Accepting Young Adult and Juvenile Patients, Chicago
- Northwestern Memorial Hospital - Accepting Adult Patients, Chicago
- The University of Chicago Medical Center - Accepting Adult and Juvenile Patients, Chicago
RekruttererFase 2/3
Alder 6 til 75 · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06154252A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- The University of Chicago Medical Center, Chicago
RekruttererFase 1
Alder 18 til 74 · Alle kjønn · Oppdatert 10. sep. 2026 · NCT07085104Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.